Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network.
Kessing LV, González-Pinto A, Fagiolini A, Bechdolf A, Reif A, Yildiz A, Etain B, Henry C, Severus E, Reininghaus EZ, Morken G, Goodwin GM, Scott J, Geddes JR, Rietschel M, Landén M, Manchia M, Bauer M, Martinez-Cengotitabengoa M, Andreassen OA, Ritter P, Kupka R, Licht RW, Nielsen RE, Schulze TG, Hajek T, Lagerberg TV, Bergink V, Vieta E. Kessing LV, et al. Among authors: yildiz a. Eur Neuropsychopharmacol. 2021 Jun;47:54-61. doi: 10.1016/j.euroneuro.2021.01.097. Epub 2021 Feb 2. Eur Neuropsychopharmacol. 2021. PMID: 33541809 Review.
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E. Pacchiarotti I, et al. Among authors: yildiz a. Am J Psychiatry. 2013 Nov;170(11):1249-62. doi: 10.1176/appi.ajp.2013.13020185. Am J Psychiatry. 2013. PMID: 24030475 Free PMC article.
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action.
Manchia M, Vieta E, Smeland OB, Altimus C, Bechdolf A, Bellivier F, Bergink V, Fagiolini A, Geddes JR, Hajek T, Henry C, Kupka R, Lagerberg TV, Licht RW, Martinez-Cengotitabengoa M, Morken G, Nielsen RE, Pinto AG, Reif A, Rietschel M, Ritter P, Schulze TG, Scott J, Severus E, Yildiz A, Kessing LV, Bauer M, Goodwin GM, Andreassen OA; European College of Neuropsychopharmacology (ECNP) Bipolar Disorders Network. Manchia M, et al. Among authors: yildiz a. Eur Neuropsychopharmacol. 2020 Jul;36:121-136. doi: 10.1016/j.euroneuro.2020.05.006. Epub 2020 Jun 12. Eur Neuropsychopharmacol. 2020. PMID: 32536571 Free article. Review.
Corrigendum to "Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121-136]".
Manchia M, Vieta E, Smeland OB, Altimus C, Bechdolf A, Bellivier F, Bergink V, Fagiolini A, Geddes JR, Hajek T, Henry C, Kupka R, Lagerberg TV, Licht RW, Martinez-Cengotitabengoa M, Morken G, Nielsen RE, González-Pinto A, Reif A, Rietschel M, Ritter P, Schulze TG, Scott J, Severus E, Yildiz A, Kessing LV, Bauer M, Goodwin GM, Andreassen OA; European College of Neuropsychopharmacology (ECNP) Bipolar Disorders Network. Manchia M, et al. Among authors: yildiz a. Eur Neuropsychopharmacol. 2021 Mar;44:121-122. doi: 10.1016/j.euroneuro.2021.01.001. Epub 2021 Jan 23. Eur Neuropsychopharmacol. 2021. PMID: 33495109 Free article. No abstract available.
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review.
Reininghaus EZ, Manchia M, Dalkner N, Bonkat N, Squassina A, Hodl I, Vieta E, Reif A, Hajek T, Landén M, Correll CU, Scott J, Etain B, Rietschel M, Bergink V, Martinez-Cengotitabengoa M, Kessing LV, Fagiolini A, Bauer M, Goodwin G, Gonzalez-Pinto A, Kupka RW, Schulze TG, Lagerberg TV, Yildiz A, Henry C, Morken G, Ritter P, Nieslen RE, Licht RW, Bechdolf A, Andreassen OA, Fellendorf FT. Reininghaus EZ, et al. Among authors: yildiz a. Eur Neuropsychopharmacol. 2022 Jan;54:90-99. doi: 10.1016/j.euroneuro.2021.09.001. Epub 2021 Sep 10. Eur Neuropsychopharmacol. 2022. PMID: 34607722 Free PMC article.
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs.
Similon MVM, Paasche C, Krol F, Lerer B, Goodwin GM, Berk M, Meyer-Lindenberg A, Ketter TA, Yatham LN, Goldberg JF, Malhi GS, El-Mallakh R, Licht RW, Young AH, Kapczinski F, Swartz M, Hagin M, Torrent C, Serretti A, Yildiz A, Martínez-Arán A, Strejilevich S, Rybakowski J, Sani G, Grunze H, Vázquez G, Pinto AG, Azorin JM, Nolen W, Sentissi O, López-Jaramillo C, Frey BN, Nierenberg A, Parker G, Bond DJ, Cohen A, Tortorella A, Perugi G, Vieta E, Popovic D. Similon MVM, et al. Among authors: yildiz a. Eur Neuropsychopharmacol. 2022 Jul;60:91-99. doi: 10.1016/j.euroneuro.2022.05.002. Epub 2022 Jun 2. Eur Neuropsychopharmacol. 2022. PMID: 35665655
1,146 results